Who Can’t Take Semaglutide? Contraindications Explained

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on peptides and GLP-1 pathways. Browse all Peptides & GLP-1 education

Semaglutide has become one of the most talked-about weight-management medications in years, and the enthusiasm is understandable. But no medication is right for everyone, and semaglutide's own FDA labeling is clear that some people should not take it. Looking past the hype means looking at the contraindications — the situations where the risks outweigh the potential benefit.

What Semaglutide Is

Semaglutide is a GLP-1 receptor agonist, FDA-approved for chronic weight management (as Wegovy) in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition, and for type 2 diabetes (as Ozempic and Rybelsus). It works by activating the GLP-1 receptor to slow stomach emptying and reduce appetite. Effective as it is for many, its labeling defines specific groups who should avoid it.

Absolute Contraindications

According to the FDA-approved labeling, semaglutide carries a boxed warning and should not be used by people with a personal or family history of medullary thyroid carcinoma (a specific thyroid cancer) or with Multiple Endocrine Neoplasia syndrome type 2, an inherited condition. It is also contraindicated in anyone with a known serious hypersensitivity to semaglutide or its ingredients. These are firm boundaries, not judgment calls.

Situations That Require Caution

Beyond the absolute contraindications, the labeling flags conditions requiring careful medical evaluation. These include a history of pancreatitis, gallbladder disease, severe gastrointestinal conditions such as gastroparesis, and diabetic retinopathy in people with type 2 diabetes. Semaglutide is not recommended during pregnancy, and providers typically advise stopping it before a planned pregnancy. Fair balance matters here: these cautions are part of the same label that describes the benefits.

Why a Provider Makes This Call

Deciding whether semaglutide is appropriate weighs your full history — family medical background, current medications, and existing conditions — against the potential benefit. That is exactly why it is a prescription medication dispensed through licensed 503A compounding pharmacies and overseen by a provider, not something to self-select. This article does not provide dosing or how-to-obtain guidance; it describes who the labeling says should be cautious or abstain.

The Genetic Variables: FTO, GLP1R, and MC4R

Contraindications answer "should you take it." Genetics answers a different, upstream question: "what is your baseline biology." Three genes anchor the weight-management pathway. FTO (variant rs9939609) is associated with higher BMI and increased hunger. MC4R governs satiety signaling in the hypothalamus and is the most common single-gene contributor to obesity. GLP1R encodes the GLP-1 receptor itself, the target every GLP-1 agonist engages, with variants such as rs6923761 studied for their influence on receptor signaling.

These variants describe your baseline appetite and receptor biology. They do not identify contraindications, and they do not predict whether semaglutide will work — a boundary worth stating clearly. Pathway-level genetics is a map of where you start, not a forecast of a drug's outcome or a substitute for clinical screening.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, dispensed through licensed 503A compounding pharmacies with provider oversight that screens for exactly these contraindications. What sets the PlexusDx approach apart is the upstream genetic context. Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including variants in FTO, GLP1R, and MC4R that shape your baseline weight-management biology. Knowing that profile is the test-before-you-invest approach, turning guesswork into an informed conversation with your healthcare provider.

Frequently Asked Questions: Who Can't Take Semaglutide

Who should not take semaglutide?

Per FDA labeling, semaglutide is contraindicated for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2, and anyone with serious hypersensitivity to it. Caution applies with pancreatitis history, gallbladder disease, severe GI conditions, and pregnancy. A provider evaluates each situation individually.

Can you take semaglutide while pregnant?

Semaglutide is not recommended during pregnancy, and providers generally advise stopping it before a planned pregnancy. Weight-management medications are not intended for use while pregnant. If you are pregnant, planning to be, or breastfeeding, discuss alternatives with a qualified healthcare provider before considering any GLP-1 protocol.

Does genetic testing tell me if I can take semaglutide?

No. The Precision Peptide Genetic Test does not identify contraindications or predict semaglutide response. It analyzes pathway-level variants in genes like FTO, GLP1R, and MC4R that describe baseline biology. Only a provider's clinical screening determines whether semaglutide is safe for you — the test informs that conversation upstream.

Where does PlexusDx fit if I may not be a candidate?

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, dispensed by licensed 503A compounding pharmacies with provider oversight that screens for contraindications. If a GLP-1 is not right for you, that screening catches it. The genetic test helps you understand your pathway biology regardless of the path you choose.

Understand your options with clinical oversight: explore the PlexusDx Weight Management Protocols, and start upstream by taking the Precision Peptide Genetic Test to see the FTO, GLP1R, and MC4R biology behind your results.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

This article is educational. PlexusDx offers semaglutide through its Weight Management Protocols — this article covers the mechanism, evidence, and genetic context that informs any decision to use it. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.